301 related articles for article (PubMed ID: 23015379)
81. Discontinuation of secondary prophylaxis for cryptococcal meningitis in human immunodeficiency virus-infected patients treated with highly active antiretroviral therapy: a prospective, multicenter, randomized study.
Vibhagool A; Sungkanuparph S; Mootsikapun P; Chetchotisakd P; Tansuphaswaswadikul S; Bowonwatanuwong C; Ingsathit A
Clin Infect Dis; 2003 May; 36(10):1329-31. PubMed ID: 12746781
[TBL] [Abstract][Full Text] [Related]
82. Multicenter Cryptococcal Antigen Screening of HIV-Infected Patients in Iran.
Bandalizadeh Z; Shokohi T; Moosazadeh M; Keikha N; Seyedpor H; Rabie Rudsari M; Babamahmoudi F; Ghasemian R; Mardani M; Javanian M; Soleimanpour S; Sefidgar AA; Shokri M; Gouya MM; Seyedmousavi S
Curr Microbiol; 2020 Aug; 77(8):1667-1672. PubMed ID: 32296917
[TBL] [Abstract][Full Text] [Related]
83. Cryptococcal immune reconstitution inflammatory syndrome: report of four cases in three patients and review of the literature.
Skiest DJ; Hester LJ; Hardy RD
J Infect; 2005 Dec; 51(5):e289-97. PubMed ID: 16321643
[TBL] [Abstract][Full Text] [Related]
84. Prevalence of cryptococcal antigenemia and cost-effectiveness of a cryptococcal antigen screening program--Vietnam.
Smith RM; Nguyen TA; Ha HT; Thang PH; Thuy C; Lien TX; Bui HT; Le TH; Struminger B; McConnell MS; Fanfair RN; Park BJ; Harris JR
PLoS One; 2013; 8(4):e62213. PubMed ID: 23626792
[TBL] [Abstract][Full Text] [Related]
85. Cryptococcal meningoencephalitis relapse after an eight-year delay: an interplay of infection and immune reconstitution.
Katchanov J; Blechschmidt C; Nielsen K; Branding G; Arastéh K; Tintelnot K; Meintjes G; Boulware DR; Stocker H
Int J STD AIDS; 2015 Oct; 26(12):912-4. PubMed ID: 25505049
[TBL] [Abstract][Full Text] [Related]
86. Practice guidelines for the management of cryptococcal disease. Infectious Diseases Society of America.
Saag MS; Graybill RJ; Larsen RA; Pappas PG; Perfect JR; Powderly WG; Sobel JD; Dismukes WE
Clin Infect Dis; 2000 Apr; 30(4):710-8. PubMed ID: 10770733
[TBL] [Abstract][Full Text] [Related]
87. Brief Report: Point of Care Cryptococcal Antigen Screening: Pipetting Finger-Prick Blood Improves Performance of Immunomycologics Lateral Flow Assay.
Wake RM; Jarvis JN; Harrison TS; Govender NP
J Acquir Immune Defic Syndr; 2018 Aug; 78(5):574-578. PubMed ID: 29771787
[TBL] [Abstract][Full Text] [Related]
88. Cryptococcal infection in HIV-infected patients with CD4
Pérez-Jacoiste Asín MA; Bisbal O; Iribarren JA; Pérez-Rivilla A; Mican R; Dronda F; González-Domenech CM; Vinuesa-García D; Macías J; Lumbreras C; Moreno S; Rubio R;
Clin Microbiol Infect; 2021 Aug; 27(8):1171.e1-1171.e7. PubMed ID: 33069858
[TBL] [Abstract][Full Text] [Related]
89. [Disseminated cryptococcosis in patients with AIDS. Clinical, microbiological, and immunological analysis of 51 patients].
Metta HA; Corti ME; Negroni R; Helou S; Arechavala A; Soto I; Villafañe MF; Muzzio E; Castello T; Esquivel P; Trione N
Rev Argent Microbiol; 2002; 34(3):117-23. PubMed ID: 12415893
[TBL] [Abstract][Full Text] [Related]
90. Neurocognitive function in HIV-infected persons with asymptomatic cryptococcal antigenemia: a comparison of three prospective cohorts.
Montgomery MP; Nakasujja N; Morawski BM; Rajasingham R; Rhein J; Nalintya E; Williams DA; Huppler Hullsiek K; Kiragga A; Rolfes MA; Donahue Carlson R; Bahr NC; Birkenkamp KE; Manabe YC; Bohjanen PR; Kaplan JE; Kambugu A; Meya DB; Boulware DR;
BMC Neurol; 2017 Jun; 17(1):110. PubMed ID: 28606065
[TBL] [Abstract][Full Text] [Related]
91. Discontinuation of secondary prophylaxis for cryptococcal meningitis in HIV-infected patients responding to highly active antiretroviral therapy.
Martínez E; García-Viejo MA; Marcos MA; Pérez-Cuevas JB; Blanco JL; Mallolas J; Miró JM; Gatell JM
AIDS; 2000 Nov; 14(16):2615-7. PubMed ID: 11101078
[No Abstract] [Full Text] [Related]
92. Challenges in diagnosis and management of Cryptococcal immune reconstitution inflammatory syndrome (IRIS) in resource limited settings.
Musubire AK; Meya BD; Mayanja-Kizza H; Lukande R; Wiesner LD; Bohjanen P; R Boulware RD
Afr Health Sci; 2012 Jun; 12(2):226-30. PubMed ID: 23056032
[TBL] [Abstract][Full Text] [Related]
93. The global burden of HIV-associated cryptococcal infection in adults in 2020: a modelling analysis.
Rajasingham R; Govender NP; Jordan A; Loyse A; Shroufi A; Denning DW; Meya DB; Chiller TM; Boulware DR
Lancet Infect Dis; 2022 Dec; 22(12):1748-1755. PubMed ID: 36049486
[TBL] [Abstract][Full Text] [Related]
94. Treatment of experimental cryptococcal meningitis with fluconazole: impact of dose and addition of flucytosine on mycologic and pathophysiologic outcome.
Kartalija M; Kaye K; Tureen JH; Liu Q; Täuber MG; Elliott BR; Sande MA
J Infect Dis; 1996 May; 173(5):1216-21. PubMed ID: 8627075
[TBL] [Abstract][Full Text] [Related]
95. High-Dose Fluconazole Consolidation Therapy for Cryptococcal Meningitis in Sub-Saharan Africa: Much to Gain, Little to Lose.
Murphy RA; Hatlen TJ; Moosa MS
AIDS Res Hum Retroviruses; 2018 May; 34(5):399-403. PubMed ID: 29353491
[TBL] [Abstract][Full Text] [Related]
96. [Cryptococcal meningitis in children: description of 3 cases].
Ndiaye M; Diagne NR; Seck LB; Sow AD; Sène MS; Diop AG; Sow HD; Ndiaye MM
Med Trop (Mars); 2011 Apr; 71(2):176-8. PubMed ID: 21695878
[TBL] [Abstract][Full Text] [Related]
97. A multicentre, randomized, double-blind, placebo-controlled trial of primary cryptococcal meningitis prophylaxis in HIV-infected patients with severe immune deficiency.
Chetchotisakd P; Sungkanuparph S; Thinkhamrop B; Mootsikapun P; Boonyaprawit P
HIV Med; 2004 May; 5(3):140-3. PubMed ID: 15139978
[TBL] [Abstract][Full Text] [Related]
98. Prevalence and correlates of cryptococcal antigen positivity among AIDS patients--United States, 1986-2012.
McKenney J; Smith RM; Chiller TM; Detels R; French A; Margolick J; Klausner JD;
MMWR Morb Mortal Wkly Rep; 2014 Jul; 63(27):585-7. PubMed ID: 25006824
[TBL] [Abstract][Full Text] [Related]
99. Survival following screening and preemptive antifungal therapy for subclinical cryptococcal disease in advanced HIV infection.
Makadzange TA; Hlupeni A; Machekano R; Boyd K; Mtisi T; Nyamayaro P; Ross C; Vallabhaneni S; Balachandra S; Chonzi P; Ndhlovu CE
AIDS; 2021 Oct; 35(12):1929-1938. PubMed ID: 34101629
[TBL] [Abstract][Full Text] [Related]
100. Cryptococcal antigenemia and its predictors among HIV infected patients in resource limited settings: a systematic review.
Derbie A; Mekonnen D; Woldeamanuel Y; Abebe T
BMC Infect Dis; 2020 Jun; 20(1):407. PubMed ID: 32527231
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
